Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Part 2 of 10: What outcomes have you observed in patients who have started Toujeo

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Part 3 of 10: What are the benefits of starting insulin naïve patients on a basal insulin instead of a premix or co-formulation insulin

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Part 4 of 10: Managing post-prandial spikes – basal and premixed insulin

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Part 5 of 10: The benefits of early combination therapies

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Part 6 of 10: How does GLP-1 complement basal insulin in the management of type 2 diabetes

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Part 7 of 10: What to expect when using Toujeo (insulin glargine 300 U/mL) plus GLP-1 therapies

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Part 8 of 10: Benefits of early combination therapy of GLP-1 and basal

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Part 9 of 10: Benefits of a second-generation basal insulin

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Part 10 of 10: Once Daily Insulins vs Once Weekly Insulin

Join Professor Robert Ritzel in this 10 part series on harnessing the synergies of Basal Insulin and GLP-1 RA Therapies

Číst více

Broschüre - Kevzara® bei PMR

Číst více

La Efectividad de Dupilumab: el efecto de los biomarcadores IT2 (FENO)

Primer estudio de RWE sobre la efectividad de Dupilumab: el efecto de los biomarcadores IT2 (FENO)

Číst více

La Efectividad de Dupilumab: seguridad y relevancia en la práctica clínica

Primer estudio de RWE sobre la efectividad de Dupilumab: seguridad y relevancia en la práctica clínica

Číst více